2nd Annual MarketsandMarkets

Advanced Genetic Sequencing Virtual Conference [Time zone- Eastern Standard Time (EST)]

3rd-4th February, 2022

In recent years, there has been an extraordinary leap in knowledge of the human genome and its role in health and disease. Advanced genetic sequencing has been revolutionizing discoveries across life sciences and has been accelerating technology that offers ultra-high throughput, scalability, and speed in modern medicine

MarketsandMarkets is extremely delighted to announce its 2nd Annual Advanced Genetic Sequencing Conference scheduled to be held on 3rd-4th February 2022. The conference is hand crafted to platform new genomics insights, holding discussions on trending technologies along with its sequencing applications, indicating the challenges in sequencing area covering, diagnostic setting/research setting, high technology cost, genome-wide target, variant interpretation, multiple tumor cell population, TCR profiling, T cell Clones, issues with accuracy & the results.

This event will witness an overwhelming participation of leading healthcare and industry decision makers who are amplifying the future and counted as some of the best minds on the planet.

WHAT TO EXPECT

  • Short Read Sequencing & Long Read Sequencing – Single Cell Analysis
  • Applications of Nanopore sequencing in healthcare
  • Deep Sequencing with NGS
  • Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease
  • Use of multi-omic, single-cell sequencing technology in understanding reservoirs of infection in HIV-infected individuals
  • Methods for the characterization of the tumor microenvironment with a Spatial Context
  • CRISPR Technology
  • Prenatal Whole Genome Sequencing
  • Applications of single-cell Omics in drug discovery

  • Learn about the recent trends and advancements occurring in Sequencing market.
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical manufactures, therapeutic companies and Healthcare who will address most critical challenges in different sequencing process.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers

Professionals in Healthcare, Therapeutics, Universities/ Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers
  • Postdocs
  • Senior Scientists
  • Senior Researchers
  • Professors
  • Bioinformatician
  • Computational Biologist

Working in departments of Bioinformatics, Genomics, Molecular Biology, Oncology, Biotechnology and Biochemistry

CONFERENCE AGENDA

Registration

10:30 - 11:00

Welcome note from MarketsandMarkets

11:00 - 11:05

Opening Remarks from the Chairman

11:05 - 11:10

Evaluating Neoantigen Immunotherapies in the Clinic

Matt Davis

Matt Davis, Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

11:10 - 11:40

OVERVIEW OF DEVELOPMENTS IN SEQUENCING TECHNOLOGY

cellenONE/cellenCHIP/proteoCHIP: disruptive technologies to get the more from each cells of your sample

Francois Monjaret

Francois Monjaret, Chief Scientific Officer, Cellenion

11:40 - 12:10

Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease

Matteo D’Antonio

Matteo D’Antonio, Assistant Professor, University of California, San Diego

12:10 - 12:40

AI enabled, label free single cell spatial biology technologies with image-guided FACS

Yuhwa Lo

Yuhwa Lo, Professor, Electrical & Computer Engineering, University of California, San Diego

12:40 - 13:10

SEQUENCING TECHNOLOGY AND ITS APPLICATIONS

Combining sequence and structure information from DNA (genomics), RNA (Coding and Noncoding), and proteins, to better understand genome organization and function

Miten Jain

Miten Jain, Assistant Research Scientist, University of California Santa Cruz

13:10 - 13:40

Methods for the characterization of the tumor microenvironment with a Spatial Context

Santhoshi Krishnan

Santhoshi Krishnan, Senior Research Student, University of Michigan

13:40 - 14:10

PRIORITIZING CHALLENGES IN SEQUENCING AREA

Integrating Bulk- Single Cell and Spatial Transcriptomics towards integrative disease understanding

Arvind Rao

Arvind Rao, Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

14:10 - 14:40

Closing Remarks from the Chairman

14:40 - 14:45

One-to-One Networking Meetings | Networking break – virtual networking lounge

14:45 - 14:45

End of Day 1

14:45 - 14:45

Registration

10:30 - 11:00

Welcome note from MarketsandMarkets

11:00 - 11:05

Opening Remarks from the Chairman

11:05 - 11:10

TAILORING MODEL’S AND THERAPIES FOR RARE DISORDERS UNDER SEQUENCING

Keynote Presentation - Single-Cell Omics Help Develop Drug Against Ovarian Cancer

Ajay Nair

Ajay Nair, Associate Research Scientist, Columbia University in the City of New York

11:10 - 11:40

“We have the technology - but what Is the solution"? The Gap between the art of the technically possible and making it work for healthcare

Vanya Gant

Vanya Gant , Consultant in Microbiology, and Infection/Director, HSL Laboratories, UCL

11:40 - 12:10

SHAPING THE GENOMIC MEDICINE ERA WITH BEST TOOLS AND METHODOLOGIES IN SEQUENCING

Comprehensive quality control and decontamination of single-cell RNA-seq data

Joshua Campbell

Joshua Campbell, Professor, Boston University School of Medicine

12:10 - 12:40

Advanced Sequencing technologies towards a better understanding of Craniofacial Development

Arun Devotta

Arun Devotta, Associate Research Scientist, New York University

12:40 - 13:10

Use of multi-omic, single-cell sequencing technology in understanding reservoirs of infection in HIV-infected individuals

 Brittany Rife

Brittany Rife, University of Florida, Research Assistant Scientist

13:10 - 13:40

Closing Remarks from the Chairman

13:40 - 13:45

One-to-One Networking Meetings | Networking break – virtual networking lounge

13:45 - 13:45

End of Conference

13:45 - 13:45

CONFERENCE SPEAKERS

ADVISORS

Kelly A Frazer

Kelly A Frazer

Director, Institute for Genomic Medicine, University of California, San Diego

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

SPEAKERS

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

Matteo D’Antonio

Matteo D’Antonio

Assistant Professor, University of California, San Diego

 Brittany Rife

Brittany Rife

University of Florida, Research Assistant Scientist

Arun Devotta

Arun Devotta

Associate Research Scientist, New York University

Joshua Campbell

Joshua Campbell

Professor, Boston University School of Medicine

Santhoshi Krishnan

Santhoshi Krishnan

Senior Research Student, University of Michigan

Yuhwa Lo

Yuhwa Lo

Professor, Electrical & Computer Engineering, University of California, San Diego

Arvind Rao

Arvind Rao

Associate Professor of Computational Medicine and Bioinformatics, Department of Computational Medicine and Bioinformatics, University of Michigan Ann Arbor

Vanya Gant

Vanya Gant

Consultant in Microbiology, and Infection/Director, HSL Laboratories, UCL

Ajay Nair

Ajay Nair

Associate Research Scientist, Columbia University in the City of New York

Francois Monjaret

Francois Monjaret

Chief Scientific Officer, Cellenion

SPONSORS

PARTNERS